MA42891B2 - Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor - Google Patents

Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor

Info

Publication number
MA42891B2
MA42891B2 MA42891A MA42891A MA42891B2 MA 42891 B2 MA42891 B2 MA 42891B2 MA 42891 A MA42891 A MA 42891A MA 42891 A MA42891 A MA 42891A MA 42891 B2 MA42891 B2 MA 42891B2
Authority
MA
Morocco
Prior art keywords
glp
glucagon
gip receptor
persistent conjugate
triple activator
Prior art date
Application number
MA42891A
Other languages
French (fr)
Other versions
MA42891A1 (en
Inventor
Sung Youb Jung
Euh Lim Oh
Chang Ki Lim
Se Chang Kwon
Young Jin Park
Jong Suk Lee
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Priority claimed from PCT/KR2016/015555 external-priority patent/WO2017116205A1/en
Publication of MA42891A1 publication Critical patent/MA42891A1/en
Publication of MA42891B2 publication Critical patent/MA42891B2/en

Links

Abstract

La présente invention concerne un conjugué persistant d'un triple activateur qui active le récepteur du glucagon, du glp-1 et du gip, et des applications du conjugué persistant.The present invention relates to a persistent conjugate of a triple activator which activates the glucagon, glp-1 and gip receptor, and applications of the persistent conjugate.

MA42891A 2015-12-31 2016-12-30 Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor MA42891B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150191082 2015-12-31
PCT/KR2016/015555 WO2017116205A1 (en) 2015-12-31 2016-12-30 Persistent conjugate of triple activator activating glucagon, glp-1 and gip receptor

Publications (2)

Publication Number Publication Date
MA42891A1 MA42891A1 (en) 2019-04-30
MA42891B2 true MA42891B2 (en) 2021-11-30

Family

ID=62104015

Family Applications (4)

Application Number Title Priority Date Filing Date
MA42889A MA42889B2 (en) 2015-12-31 2016-12-30 Triple activator activating the glucagon, glp-1 and gip receptor
MA42891A MA42891B2 (en) 2015-12-31 2016-12-30 Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor
MA51955A MA51955B1 (en) 2015-12-31 2016-12-30 Triple activator activating glucagon, glp-1 and gip receptor
MA53533A MA53533A1 (en) 2015-12-31 2018-07-26 Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MA42889A MA42889B2 (en) 2015-12-31 2016-12-30 Triple activator activating the glucagon, glp-1 and gip receptor

Family Applications After (2)

Application Number Title Priority Date Filing Date
MA51955A MA51955B1 (en) 2015-12-31 2016-12-30 Triple activator activating glucagon, glp-1 and gip receptor
MA53533A MA53533A1 (en) 2015-12-31 2018-07-26 Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor

Country Status (3)

Country Link
AR (2) AR107281A1 (en)
MA (4) MA42889B2 (en)
MY (1) MY199261A (en)

Also Published As

Publication number Publication date
AR107282A1 (en) 2018-04-18
MY199261A (en) 2023-10-23
MA51955A1 (en) 2021-10-29
MA42889B2 (en) 2020-11-30
MA42891A1 (en) 2019-04-30
AR107281A1 (en) 2018-04-18
MA51955B1 (en) 2022-04-29
MA53533A1 (en) 2022-08-31
MA42889A1 (en) 2018-11-30

Similar Documents

Publication Publication Date Title
MX2018008128A (en) Persistent conjugate of triple activator activating glucagon, glp-1 and gip receptor.
CL2023001910A1 (en) Glucagon derivative and a composition comprising a long-acting conjugate thereof
MA43187A (en) SUBCUTANEOUS ANTI-CD38 ANTIBODY FORMULATIONS AND THEIR USES
MX2020003217A (en) Long-acting co-agonists of the glucagon and glp-1 receptors.
MX2020005483A (en) Ildr2 antagonists and combinations thereof.
WO2017074798A3 (en) Long-acting co-agonists of the glucagon and glp-1 receptors
TR201901516T4 (en) Neuroprotective agents and their uses.
CL2019003037A1 (en) Fungicidal combinations.
MA53533A1 (en) Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor
EA201691422A1 (en) ORIGINALLY FALLING TABLETED MEMANTINE COMPOSITIONS
UA120448U (en) FUNGICID COMPOSITION
EA201992475A1 (en) COMBINATION CONTAINING SUCH A PPAR AGONIST AS ELAFIBRANOR AND ACETYL-COA-CARBOXYLASE (ACC) INHIBITOR
UA120068C2 (en) FUNGICIDAL COMPOSITION
UA114469U (en) APPLICATION OF CAPICOR PREPARATION (MELDONIA DIGITRATE AND γ-BUTYROBETAINE DIGITRATE) AS A NEPHROPROTECTOR
EA201991993A1 (en) APPLICATION OF PHENYLCREATIN AS A NOOTROPIC AGENT
UA108342U (en) 7-N-BUTYL-8-N, N-DIETHYLAMINOETHYLAMIN-3-METHYLXANTINE SUCCINATE, WHICH HAS DIURETIC AND ANALGETIC ACTION
UA100710U (en) APPLICATION OF FITOVENOL Capsules AS A HEPATOPROTECTOR
MA39074B1 (en) Combination therapy with an anti-ang 2 antibody and a cd40 agonist
RU2013145736A (en) FUSION COMPOSITION FOR EMULSION FLEGMATIZATION OF POWDERS